StockNews.com Upgrades ICU Medical (NASDAQ:ICUI) to "Buy"

ICU Medical (NASDAQ:ICUI - Get Free Report) was upgraded by stock analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Friday.

A number of other research analysts also recently weighed in on ICUI. KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $162.67.

ICU Medical Stock Up 3.4 %

Shares of ICUI stock traded up $4.67 during mid-day trading on Friday, hitting $141.64. The company's stock had a trading volume of 174,792 shares, compared to its average volume of 274,714. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 52-week low of $96.97 and a 52-week high of $196.26. The stock has a market cap of $3.49 billion, a price-to-earnings ratio of -30.99 and a beta of 0.86. The business has a 50-day moving average price of $141.61 and a 200 day moving average price of $156.43.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Barclays PLC lifted its stake in shares of ICU Medical by 15.6% during the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock valued at $10,790,000 after buying an additional 8,010 shares in the last quarter. Franklin Resources Inc. lifted its holdings in ICU Medical by 99.3% in the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after purchasing an additional 5,834 shares in the last quarter. Principal Financial Group Inc. boosted its stake in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares during the period. Diversified Trust Co raised its position in shares of ICU Medical by 32.3% during the fourth quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock valued at $512,000 after buying an additional 805 shares during the last quarter. Finally, Inspire Investing LLC lifted its holdings in shares of ICU Medical by 13.2% in the fourth quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock worth $404,000 after buying an additional 303 shares in the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.